Diagnostic Application of Immunophenotypic Analysis of Erythroid Dysplasia in Myelodysplastic Syndromes. a Report on Behalf of the European Leukemianet-IMDS-Flow Cytometry Working Group
Theresia M. Westers(Vrije Universiteit Amsterdam), Arjan van de Loosdrecht(Amsterdam University Medical Centers), Birgit I. Lissenberg‐Witte(OLVG), Wolfgang Kern(Munich Leukemia Laboratory (Germany)), Eline M.P. Cremers(Cancer Center Amsterdam), Matteo Giovanni Della Porta(Humanitas University), Uta Oelschlaegel(University Hospital Carl Gustav Carus), Peter Bettelheim, Ulrika Johansson(University Hospitals Bristol NHS Foundation Trust)
Cited by 0
Related Papers
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2021|714